Brief: Singapore Edevelopment Says Proved In Vitro Success Of Equivir & 3F Biofragrance Against Covid-19
24/06/2020 11:30
June 24 (Reuters) - Singapore eDevelopment Ltd SINE.SI :
* SINGAPORE EDEVELOPMENT- PROVED IN VITRO SUCCESS OF EQUIVIR
& 3F
BIOFRAGRANCE AGAINST COVID-19 IN INDEPENDENT LABORATORY TESTING
Source text for Eikon: ID:nSN7lMDHM
Further company coverage: SINE.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alset International
See all newsSingapore's Alset International half-year revenue rises sharply on food and beverage business
Brief: Alset International Posts HY Loss Attributable S$4.5 Million
Brief: Alset International Announces Formation Of Joint Venture
Brief: Alset International Posts HY Loss Attributable From Continuing Operations Of S$14.1 Mln
Brief: Alset International Says Entered Two Stock Purchase Agreements